- Home
- OSRH vs SNGX Comparison
OSRH vs SNGX Comparison
Compare OSRH & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- SNGX
- Stock Information
- Founded
- OSRH N/A
- SNGX 1987
- Country
- OSRH United States
- SNGX United States
- Employees
- OSRH N/A
- SNGX N/A
- Industry
- OSRH
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- OSRH
- SNGX Health Care
- Exchange
- OSRH Nasdaq
- SNGX Nasdaq
- Market Cap
- OSRH 11.1M
- SNGX 10.1M
- IPO Year
- OSRH N/A
- SNGX 1987
- Fundamental
- Price
- OSRH $0.70
- SNGX $2.81
- Analyst Decision
- OSRH
- SNGX Strong Buy
- Analyst Count
- OSRH 0
- SNGX 1
- Target Price
- OSRH N/A
- SNGX $6.00
- AVG Volume (30 Days)
- OSRH 13.9M
- SNGX 659.7K
- Earning Date
- OSRH 08-14-2025
- SNGX 11-07-2025
- Dividend Yield
- OSRH N/A
- SNGX N/A
- EPS Growth
- OSRH N/A
- SNGX N/A
- EPS
- OSRH N/A
- SNGX N/A
- Revenue
- OSRH $104,735.00
- SNGX N/A
- Revenue This Year
- OSRH N/A
- SNGX N/A
- Revenue Next Year
- OSRH N/A
- SNGX N/A
- P/E Ratio
- OSRH N/A
- SNGX N/A
- Revenue Growth
- OSRH N/A
- SNGX N/A
- 52 Week Low
- OSRH $0.45
- SNGX $1.09
- 52 Week High
- OSRH $13.40
- SNGX $6.23
- Technical
- Relative Strength Index (RSI)
- OSRH 50.81
- SNGX 49.49
- Support Level
- OSRH $0.57
- SNGX $2.58
- Resistance Level
- OSRH $0.62
- SNGX $2.98
- Average True Range (ATR)
- OSRH 0.08
- SNGX 0.19
- MACD
- OSRH 0.02
- SNGX -0.07
- Stochastic Oscillator
- OSRH 44.73
- SNGX 35.94
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).